latent autoimmune diabetes of adults (LADA)
- a subgroup of patients diagnosed earlier as type 2 diabetes (around 12%)
(1) has circulating autoantibodies
- circulating autoantibodies are to islet cell cytoplasmatic antigens
(ICA) and more frequently to glutamic acid decarboxilase (GAD, GADab)
- circulating autoantibodies are to islet cell cytoplasmatic antigens (ICA) and more frequently to glutamic acid decarboxilase (GAD, GADab) (2)
- patients were reported earlier as type 1 diabetes, but according to the
WHO Classification of diabetes mellitus it is called now Latent Autoimmune
Diabetes in Adults (LADA) (3 and 4)
- LADA could be a part of the type 2 diabetes since its onset is in the
- LADA shows some characteristics of type 2 diabetes, which is a heterogenous disease that results from a combination of abnormalities in both insulin secretion and insulin action
- LADA cases are usually with genuine insulin deficiency, many are non-obese with a beta-cell secretory defect (3). This compares with other cases of type 2 diabetes where hyperinsulinaemia is a characteristic feature
- in consideration of the genetic factors influencing the development
of LADA (5):
- the most important genetic risk factors for LADA is heterozygosity for DR3-DQ2/DR4-DQ8 followed by heterozygosity for MICA5.0/5.1, and finally to some extent homozygosity for DR3-DQ2
- DR15-DQ6 is a protective factor for type 1 diabetes and to some
extent for LADA
- LADA could be a part of the type 2 diabetes since its onset is in the adulthood,
- some alternate the terms LADA and type 1.5 diabetes (6)
- people diagnosed with LADA are usually over age 30
- M. Pietropaolo et al.Evidence of Islet cell autoimmunitiy in elderly patients with Type 2 diabetes. Diabetes 49 (2000): 32-38.
- T. Tuomi et al.Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48 (1999): 150–157.
- P.Z. Zimmet et al.atent autoimmune diabetes mellitus in adults (LADA): the role of autoantibodies to glutamic acid decarboxilase in diagnosis and prediction of insulin dependency. Diabetic Med. 11 (1994):299–303.
- for the WHO consultation, K.G.M.M. Alberti and P.Z. Zimmet , Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional Report of a WHO consultation. Diabetic Med. 15 1998 (1998), pp. 539–553.
- Torn C et al. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes. Human Immunology (2003); 64 (9): 902-909.
- "Latent autoimmune diabetes". Mayo Clinic. Retrieved September 28th, 2016.
Last reviewed 01/2018